In November, McDermott Will & Emery was pleased to host our annual European Health & Life Sciences Symposium in Paris. Welcoming a large crowd of healthcare professionals, investors and dealmakers for a programme of...more
1/22/2024
/ Algorithms ,
Artificial Intelligence ,
Big Data ,
EU ,
Health Information Technologies ,
Healthcare ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Privacy Laws ,
Technology Sector
200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more
10/19/2023
/ Artificial Intelligence ,
Events ,
Financing ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
RUSSIA RESPONDS TO WESTERN SANCTIONS WITH PATENT RETALIATION -
On March 6, 2022, the Russian government retaliated against the West’s imposition of sanctions by issuing a decree permitting patented innovations to be used...more
6/27/2022
/ Appeals ,
Biotechnology ,
Cosmetics ,
Dietary Supplements ,
EU ,
France ,
Intellectual Property Protection ,
Medical Devices ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Russia ,
Sanctions ,
Trademark Litigation ,
Trademarks
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more
6/1/2022
/ Anti-Kickback Statute ,
Artificial Intelligence ,
Cross-Border ,
Global Market ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Medical Technology Companies ,
Merger Controls ,
Pharmaceutical Industry ,
Technology Sector ,
Telemedicine
UNIFIED PATENT COURT -
The Unified Patent Court (UPC) should become a reality in 2022 or in the first few months of 2023.
The Protocol on Provisional Application (PPA) of the Agreement on a Unified Patent Court (AUPC)...more
2/21/2022
/ EU ,
France ,
Healthcare ,
Manufacturers ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trademarks ,
Unfair Competition
Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and...more
9/29/2021
/ Counterfeiting ,
EU ,
France ,
Intellectual Property Protection ,
Inventions ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Revocation ,
Trademark Infringement ,
Trademark Invalidity ,
Trademarks
On 11 June 2021, the German Federal Parliament approved the draft bill on corporate due diligence in supply chains (Supply Chain Due Diligence Act), which was approved by the German Federal Council without any changes on 25...more
7/13/2021
/ Acquisitions ,
Annual Reports ,
Competent Authority (CA) ,
Due Diligence ,
Duty of Care ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Germany ,
Human Rights ,
Italy ,
Liability ,
Mergers ,
Modern Slavery Act ,
New Legislation ,
Risk Management ,
Sanctions ,
Supply Chain ,
Sustainability ,
UK ,
United States ,
Whistleblowers
Given the challenges of conducting clinical trials during the COVID-19 pandemic, many countries — including France — have allowed for some use of remote quality controls. In response to guidelines issued recently by European...more
5/5/2021
/ Clinical Trials ,
CNIL ,
Compliance ,
Coronavirus/COVID-19 ,
Data Protection ,
EU ,
France ,
Personal Data ,
Personally Identifiable Information ,
Policies and Procedures ,
Public Health Emergency ,
Quality Control Plan
Companies frequently encounter challenges in the manufacture and supply of their innovative products, in particular with respect to process development and production capacity.
In our latest webinar, we review how key...more
3/17/2021
/ Biotechnology ,
Capacity ,
Intellectual Property Protection ,
Liability ,
Life Sciences ,
Manufacturers ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Supply Agreements ,
Warranties ,
Webinars